Neonatal multidrug-resistant bacterial meningitis: a 29-year study from a tertiary hospital in Thailand

Anucha Thatrimontrichai1, Waricha Janjindamai2, Supaporn Dissaneevate2

  • 1Division of Neonatology, Department of Pediatrics, Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand. tanucha@medicine.psu.ac.th.

Abstract

Insights

Neonatal multidrug-resistant (MDR) meningitis is linked to lower Apgar scores and significantly higher mortality rates compared to non-MDR meningitis. Strict infection control is vital, especially with Acinetobacter baumannii.

Area of Science:

  • Neonatal Medicine
  • Infectious Diseases
  • Microbiology

Background:

  • Neonatal meningitis poses a significant threat to infant health.
  • The rise of multidrug-resistant (MDR) organisms complicates treatment and increases mortality.
  • Understanding the specific risks associated with MDR meningitis is crucial for effective intervention.

Purpose of the Study:

  • To compare the risks and case fatality rate (CFR) of neonatal meningitis caused by multidrug-resistant (MDR) versus non-MDR organisms.
  • To identify specific risk factors and outcomes associated with MDR neonatal meningitis.

Main Methods:

  • A secondary analysis of a case-control study conducted in a Thai neonatal intensive care unit from 1990 to 2018.
  • Defined MDR organisms as non-susceptible to at least 1 agent in at least 3 antimicrobial categories.
  • Utilized multivariate regression to analyze data from MDR and non-MDR neonatal meningitis cases.

Main Results:

  • Over 29 years, 17 MDR and 21 non-MDR neonatal meningitis cases were identified.
  • Neonates with MDR meningitis had lower Apgar scores (aOR=0.66; 95% CI=0.44-0.99).
  • The crude CFR was 32%; MDR meningitis had a significantly higher non-survival rate (58.8%) compared to non-MDR (9.5%). Carbapenem-resistant Acinetobacter baumannii was the most common pathogen in non-survivors.

Conclusions:

  • Neonatal MDR meningitis is associated with poorer outcomes, including lower Apgar scores and increased mortality.
  • Acinetobacter baumannii, particularly carbapenem-resistant strains, is a significant pathogen in fatal MDR meningitis cases.
  • Implementing comprehensive infection prevention and control programs for MDR organisms is essential in high-prevalence areas.